Skip to content
Jun 15 2021

RALES

Core Landmark Research, EBM, Landmark Research
Spironolactone improves mortality and morbidity in patients with HFrEF
Read more
Feb 14 2020

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease (AFIRE)

EBM, Journal Club

Thank you Nikita for leading us through a discussion of the AFIRE trial.

Clinical Question:

In patients with atrial fibrillation and stable CAD >1 year after revascularization (or confirmed CAD on angiography not requiring revascularization), how does rivaroxaban monotherapy compare to rivaroxaban plus an antiplatelet agent in terms of efficacy and safety?

Read more

December 2019

  • Olive View Internal Medicine Residency

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)

Read more

Congratulations to Dr. Sal Hernandez

Congratulations to our very own Dr. Salvador Hernandez for his recent important work on the prevalence of chronic comorbidities among people with Chagas Disease in Los Angeles. Dr. Hernandez works closely with the Center of Excellence for Chagas Disease (CECD)…

Read more
Nov 13 2019

Morning report – High-Output Heart Failure

Morning Report

Thank you to Dr. Thetford for presenting a rare case of TIPS induced high output heart failure. A few take away points: HOHF is a rare form of heart failure caused by increased CO and decreased SVR Common causes: Obesity,…

Read more

September 2019

  • Olive View Internal Medicine Residency

This month, we look at treatments for atrial fibrillation and rheumatoid arthritis. These treatments are commonly used for our patients at Olive View. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (ROCKET-AF) Therapies for Active Rheumatoid Arthritis after Methotrexate Failure

Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.